Elad Gil (solo GP)

eladgil.com

VCMatch tracks Elad Gil (solo GP) as an investor focused on AI/ML, Enterprise SaaS, and Developer Tools companies. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

AI/ML, Enterprise SaaS, Developer Tools

Geography

Not specified

Investment Thesis

Elad Gil invests and incubates companies with a long-term, future-focused view of technology—what he describes as work “focused on the technology future.” He combines founder/operator experience (serial entrepreneurship and senior product roles at Google and Twitter) with hands-on incubation, advising and occasionally starting companies, preferring deep technology bets (notably AI and longevity) and helping companies scale post–product/market fit.

Is Elad Gil (solo GP) right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Elad Gil (solo GP) is most relevant for founders raising venture-backed rounds in AI/ML, Enterprise SaaS, Developer Tools, and Data Infrastructure.

Focus statement

Focused on early-stage and growth technology companies, with particular emphasis on AI/ML, longevity/biotech, and projects that build large institutions or societal infrastructure; he explicitly notes he has been "working on a series of investments, incubations, and operating companies focused on the technology future."

Value Add

Founder-operator background: started companies (Mixerlabs, Color Health) and served as VP at Twitter and product roles at Google.
Active incubator/creator: recently "incubated / helped start Braintrust" and "Brain Co" and lists "Projects I need help with" showing a hands-on, builder role.
Deep AI credibility: "I got involved with ML & generative AI early," has run AI-centric product orgs, hosts an AI podcast (No Priors), and invested early in OpenAI, Mistral, Perplexity, etc.
Scientific credibility in biotech/longevity: holds degrees in Math and Biology ("including a PhD from MIT"), personally identified a gene involved in lifespan, and funded clinical trials.
Tactical scaling expertise: author of the "High Growth Handbook" providing practical advice for post–product/market-fit companies.